Manolo Carta, Ph.D.
Affiliations: | 2010- | Biomedical Sciences | Cagliari University |
Google:
"Manolo Carta"Mean distance: 15.36 (cluster 11)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Corsi S, Scheggi S, Pardu A, et al. (2023) Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370]. Experimental Neurology. 114640 |
| Serra M, Di Maio A, Bassareo V, et al. (2023) Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration. Neurobiology of Disease. 106226 |
| Di Maio A, Nuzzo T, Gilio L, et al. (2023) Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients. Neurobiology of Disease. 106203 |
| Corsi S, Stancampiano R, Carta M. (2021) Serotonin/dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesia: An update. Progress in Brain Research. 261: 287-302 |
| Scheggi S, Rossi F, Corsi S, et al. (2020) BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease |
| Meloni M, Puligheddu M, Sanna F, et al. (2020) Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding. Journal of the Neurological Sciences. 415: 116869 |
| Waters S, Sonesson C, Svensson P, et al. (2020) Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics |
| Meloni M, Puligheddu M, Carta M, et al. (2020) Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding. European Journal of Neurology |
| Corsi S, Scheggi S, Rossi F, et al. (2020) P.208 BDNF overexpression exacerbates D1R agonist-induced dyskinesia in hemiparkinsonian rats via D1R-D3R heteromers formation European Neuropsychopharmacology. 31 |
| Cocco C, Corda G, Lisci C, et al. (2019) VGF peptides as novel biomarkers in Parkinson's disease. Cell and Tissue Research |